Publication: Hepatic and serum branched-chain fatty acid profile in patients with nonalcoholic fatty liver disease: A case–control study
Loading...
Date
2023-04-01
Authors
María Ángeles Núñez-Sánchez ; José Ignacio Martínez-Montoro ; María Antonia Martinez-Sanchez ; Andrés Balaguer-Román ; Fernández Ruiz, Virginia Esperanza ; Tomasz Sledzinski ; María Dolores Frutos ; José Carlos Fernández-García ; Adriana Mika ; Bruno Ramos-Molina ; Ferrer Gómez, Mercedes
item.page.secondaryauthor
item.page.director
Publisher
publication.page.editor
publication.page.department
DOI
10.1002/oby.23711
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Objective: Alterations in the hepatic lipidome are a crucial factor involved in the pathophysiology of nonalcoholic fatty liver disease (NAFLD). The aim of this study was to evaluate the serum and hepatic profile of branched-chain fatty acids (BCFAs) in patients with different stages of NAFLD.
Methods: This was a case-control study performed in 27 patients without NAFLD, 49 patients with nonalcoholic fatty liver, and 17 patients with nonalcoholic steatohepatitis, defined by liver biopsies. Serum and hepatic levels of BCFAs were analyzed by gas chromatography-mass spectrometry. The hepatic expression of genes involved in the endogenous synthesis of BCFAs was analyzed by real-time quantitative polymerase chain reaction (RT-qPCR).
Results: A significant increase in hepatic BCFAs was found in subjects with NAFLD compared with those without NAFLD; no differences were observed in serum BCFAs between study groups. Trimethyl BCFAs, iso-BCFAs, and anteiso-BCFAs were increased in subjects with NAFLD (either nonalcoholic fatty liver or nonalcoholic steatohepatitis) compared with those without NAFLD. Correlation analysis showed a relationship between hepatic BCFAs and the histopathological diagnosis of NAFLD, as well as other histological and biochemical parameters related to this disease. Gene expression analysis in liver showed that the mRNA levels of BCAT1, BCAT2, and BCKDHA were upregulated in patients with NAFLD.
Conclusions: These results suggest that the increased production of liver BCFAs might be related to NAFLD development and progression.
publication.page.subject
Citation
Martínez-Montoro JI, Núñez-Sánchez MÁ, Martinez-Sanchez MA, Balaguer-Román A, Fernández-Ruiz VE, Ferrer-Gómez M, Sledzinski T, Frutos MD, Fernández-García JC, Mika A, Ramos-Molina B. Hepatic and serum branched-chain fatty acid profile in patients with nonalcoholic fatty liver disease: A case-control study. Obesity (Silver Spring). 2023 Apr;31(4):1064-1074. doi: 10.1002/oby.23711. Epub 2023 Mar 6. PMID: 36876627.
item.page.embargo
Collections
Ir a Estadísticas
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/